Animas, a division of Johnson & Johnson, announced the recall of approximately 384,000 insulin pumps, or 5% of its yearly production, today. The pumps are potentially leaky, which can cause them to deliver less insulin to the patient than intended. Insufficient insulin can cause high blood sugar and the potentially fatal condition known as diabetic ketoacidosis. Additionally, the pump can fail to sound an alarm when it should. To date, Animas has received notice of 22 failures thus far. Animas has informed the FDA of the recall.